Lv6
2748 积分 2020-07-27 加入
Next-generation JAK inhibitors in the treatment of myeloproliferative neoplasms
11天前
已完结
CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons
11天前
已完结
New Binding Sites for JAK2 Inhibition in Myeloproliferative Neoplasms: Structural Insights, Therapeutic Potential, and Future Directions
11天前
已完结
BTK inhibitors and next-generation BTK-targeted therapeutics for B-cell malignancies
18天前
已完结
Involvement of Btk in Cardiovascular Disease and Its Therapeutic Targeting
18天前
已完结
SOHO State of the Art Updates and Next Questions: Updates on BTK Inhibitors for the Treatment of Chronic Lymphocytic Leukemia
18天前
已完结
JAK2V617F negatively regulates p53 stabilization by enhancing MDM2 via La expression in myeloproliferative neoplasms
20天前
已完结
Merging PROTAC and molecular glue for degrading BTK and GSPT1 proteins concurrently
22天前
已完结
BTK inhibitors resistance in B cell malignancies: Mechanisms and potential therapeutic strategies
22天前
已完结
Different subsets of primary chronic myeloid leukemia stem cells engraft immunodeficient mice and produce a model of the human disease
1个月前
已完结
皖公网安备34019202002308
